BE554750A - - Google Patents
Info
- Publication number
- BE554750A BE554750A BE554750DA BE554750A BE 554750 A BE554750 A BE 554750A BE 554750D A BE554750D A BE 554750DA BE 554750 A BE554750 A BE 554750A
- Authority
- BE
- Belgium
- Prior art keywords
- volume
- materials
- containing antigens
- inactivating agent
- sterile
- Prior art date
Links
- 239000000427 antigen Substances 0.000 claims description 23
- 108091007433 antigens Proteins 0.000 claims description 23
- 102000036639 antigens Human genes 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 230000000415 inactivating effect Effects 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 239000012153 distilled water Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 241000700605 Viruses Species 0.000 claims description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 229940124452 immunizing agent Drugs 0.000 claims description 9
- 230000000711 cancerogenic effect Effects 0.000 claims description 8
- 231100000315 carcinogenic Toxicity 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 8
- OTIXUSNHAKOJBX-UHFFFAOYSA-N 1-(aziridin-1-yl)ethanone Chemical compound CC(=O)N1CC1 OTIXUSNHAKOJBX-UHFFFAOYSA-N 0.000 claims description 7
- 230000002458 infectious effect Effects 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 241000699670 Mus sp. Species 0.000 claims description 6
- 208000015181 infectious disease Diseases 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 239000007858 starting material Substances 0.000 claims description 5
- 208000000832 Equine Encephalomyelitis Diseases 0.000 claims description 4
- 238000007710 freezing Methods 0.000 claims description 4
- 230000008014 freezing Effects 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 239000003053 toxin Substances 0.000 claims description 4
- 231100000765 toxin Toxicity 0.000 claims description 4
- 108700012359 toxins Proteins 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 208000000474 Poliomyelitis Diseases 0.000 claims description 3
- 239000007900 aqueous suspension Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 102100031680 Beta-catenin-interacting protein 1 Human genes 0.000 claims 1
- 101000993469 Homo sapiens Beta-catenin-interacting protein 1 Proteins 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 239000000243 solution Substances 0.000 description 13
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 7
- 229960000380 propiolactone Drugs 0.000 description 7
- 229960005486 vaccine Drugs 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 239000008174 sterile solution Substances 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 239000003708 ampul Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 231100000563 toxic property Toxicity 0.000 description 4
- 230000000890 antigenic effect Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- OXJUJQDEISSCTB-UHFFFAOYSA-N but-3-en-2-imine Chemical compound CC(=N)C=C OXJUJQDEISSCTB-UHFFFAOYSA-N 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical group O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000010981 drying operation Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000005414 inactive ingredient Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36161—Methods of inactivation or attenuation
- C12N2770/36163—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE554750A true BE554750A (enExample) |
Family
ID=179090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE554750D BE554750A (enExample) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE554750A (enExample) |
-
0
- BE BE554750D patent/BE554750A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0604631B1 (fr) | Utilisation d'enveloppes de bactéries de l'ordre des Beggiatoales ou du genre Vitreoscilla comme ingrédient actif d'un médicament destiné à stimuler l'immunité non-spécifique | |
| CA1227132A (fr) | Preparation a activite collagenolytique ayant une activite elevee et compositions pharmaceutiques la contenant | |
| CA1340524C (fr) | Procede de preparation d'acides aryl-2 propioniques optiquement actifs | |
| FR2552326A1 (fr) | Composition d'extrait soluble de pyridine et d'endotoxine detoxifiee raffinee et son utilisation | |
| EP2326708B1 (fr) | Microorqanismes photosynthétiques enrichis en sélénium à partir de composés séléno-hydroxyacides, leurs applications en nutrition, cosmétique et pharmacie | |
| CA2735254A1 (fr) | Microorganismes non photosynthetiques enrichis en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie | |
| BE554750A (enExample) | ||
| WO2022129816A1 (fr) | Milieu de culture, procede de fabrication et procede de culture bacterienne | |
| FR2515518A1 (fr) | Procede de production de preparations immunobiologiques applicables pour le diagnostic, la prevention et/ou le traitement d'infections par le candida guilliermondii, et preparations immunobiologiques en resultant | |
| FR2538703A1 (fr) | Vaccin vivant pour la prevention de la salmonellose des oiseaux aquatiques et procede pour sa preparation | |
| FR2471189A1 (fr) | Procede de preparation d'un agent anti-tumoral comprenant un composant cellulaire de streptococcus pyogenes | |
| BE882619A (fr) | Vaccin pour le controle de la pleuropneumonie chez le porc | |
| FR2485926A1 (fr) | Composition pharmaceutique comprenant un derive de l'acide aminobenzoique pour reguler les prostaglandines | |
| BE564037A (enExample) | ||
| CH431819A (fr) | Procédé de préparation d'un vaccin | |
| FR2630008A1 (fr) | Poudre de vers de terre sechee utile comme medicament et procede pour sa preparation | |
| EP0023178A1 (fr) | Procédé de préparation de solutions concentrées d'amygdaline sous sa forme naturelle | |
| FR3077067A1 (fr) | Encapsulation de substances actives et/ou de microorganismes dans un materiau lamellaire | |
| BE554749A (enExample) | ||
| FR2470765A1 (fr) | Nouveaux sels d'addition d'acides du 4'-(9-acridinyl-amino)methanesulf-m-anisidide, leur procede de production et composition pharmaceutique les contenant | |
| FR2499855A1 (fr) | Nouvelles substances a action carcinostatique et immuno-stimulante, procede pour les preparer a partir de bacteries du genre fusobacterium, et agent carcinostatique contenant de telles substances | |
| FR2582672A1 (fr) | Procede pour obtenir un polysaccharide azote isole sous forme d'adsorbat | |
| BE1003486A5 (fr) | Procede d'obtention de l'inhibiteur de la neuraminidase du virus de la grippe. | |
| FR2700172A1 (fr) | Procédé de culture de bactéries filamenteuses non photosynthétiques et non fructifiantes. | |
| FR2522268A1 (fr) | Vaccin anti-ourlien vivant et procede pour le stabiliser |